News
Veraxa Biotech has entered a joint discovery partnership with OmniAb for developing a bispecific antibody drug conjugate programme.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback